COVID-19 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) (For LF Reader) (Qualitative Result)
COVID-19 and Influenza A+B Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B virus antigens present in human nasopharyngeal swab specimens that can be performed with the use of the LF Reader.
Product Features
Fast results
Simple Operation (Less Training Required)
Objective (Results Read by Analyzer)
High Accuracy
Product Specification
PrincipleChromatographic Immunoassay
FormatCassette
SpecimenNasopharyngeal Swab
CertificateCE
Reading Time15 minutes
Pack20 T
Storage Temperature2-30°C
Shelf Life2 Years
Sensitivity97.1%(COVID-19) / 95.0%(Influenza A) / 92.9%(Influenza B)
Specificity99.1%(COVID-19) / 99.1%(Influenza A) / 99.1%(Influenza B)
Accuracy98.2%(COVID-19) / 98.4%(Influenza A) / 98.1%(Influenza B)
Ordering Information
Cat. No.
Product
Specimen
Pack
Cut-Off
ICIC-R525
COVID-19 and Influenza A+B Antigen Combo Rapid Test